8,768 Shares in Globe Life Inc. $GL Acquired by Dockside LLC

Dockside LLC acquired a new position in Globe Life Inc. (NYSE:GL) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 8,768 shares of the company’s stock, valued at approximately $1,226,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in GL. CYBER HORNET ETFs LLC acquired a new position in shares of Globe Life in the second quarter worth approximately $28,000. Hilton Head Capital Partners LLC acquired a new position in shares of Globe Life in the fourth quarter worth approximately $30,000. MUFG Securities EMEA plc acquired a new position in shares of Globe Life in the second quarter worth approximately $31,000. Torren Management LLC acquired a new position in shares of Globe Life in the fourth quarter worth approximately $37,000. Finally, Banque Cantonale Vaudoise acquired a new position in shares of Globe Life in the third quarter worth approximately $50,000. 81.61% of the stock is owned by institutional investors and hedge funds.

Globe Life Price Performance

Shares of GL opened at $166.75 on Monday. Globe Life Inc. has a 52-week low of $116.73 and a 52-week high of $168.27. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.07 and a current ratio of 0.07. The business’s 50 day moving average price is $152.88 and its two-hundred day moving average price is $144.60. The firm has a market cap of $12.95 billion, a PE ratio of 11.53 and a beta of 0.49.

Globe Life (NYSE:GL) last issued its quarterly earnings results on Wednesday, April 22nd. The company reported $3.43 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.46 by ($0.03). Globe Life had a net margin of 19.38% and a return on equity of 20.94%. The business had revenue of $1.56 billion during the quarter, compared to analyst estimates of $1.56 billion. During the same period last year, the firm posted $3.07 earnings per share. Globe Life’s quarterly revenue was up 5.3% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. On average, equities analysts anticipate that Globe Life Inc. will post 15.64 EPS for the current year.

Globe Life Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Monday, July 6th will be paid a $0.33 dividend. The ex-dividend date of this dividend is Monday, July 6th. This represents a $1.32 annualized dividend and a yield of 0.8%. Globe Life’s payout ratio is 9.13%.

Insider Transactions at Globe Life

In other news, CEO James Matthew Darden sold 4,663 shares of the company’s stock in a transaction that occurred on Tuesday, April 28th. The stock was sold at an average price of $153.88, for a total transaction of $717,542.44. Following the transaction, the chief executive officer directly owned 58,451 shares of the company’s stock, valued at $8,994,439.88. This represents a 7.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Frank M. Svoboda sold 20,000 shares of the company’s stock in a transaction that occurred on Friday, May 22nd. The stock was sold at an average price of $156.68, for a total value of $3,133,600.00. Following the transaction, the chief executive officer directly owned 54,020 shares in the company, valued at $8,463,853.60. The trade was a 27.02% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 105,929 shares of company stock valued at $16,382,450 over the last ninety days. Company insiders own 2.11% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently commented on GL shares. Morgan Stanley lifted their price objective on Globe Life from $176.00 to $181.00 and gave the stock an “overweight” rating in a research note on Thursday, May 21st. Evercore set a $157.00 price objective on Globe Life in a research note on Wednesday, February 18th. Truist Financial lifted their price objective on Globe Life from $180.00 to $185.00 and gave the stock a “buy” rating in a research note on Friday, April 24th. Piper Sandler boosted their price target on Globe Life from $167.00 to $175.00 and gave the company an “overweight” rating in a research note on Tuesday, May 26th. Finally, Keefe, Bruyette & Woods reissued a “moderate buy” rating and issued a $168.00 price target on shares of Globe Life in a research note on Thursday, March 26th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $174.11.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.